Dose Extension Study of BIIX 1 XX in Healthy Young Male Volunteers
NCT02198287 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2014-07-23
Summary
Safety, tolerability and pharmacokinetic study of BIIX 1 XX in healthy male volunteers.
Conditions
- Healthy
Interventions
- DRUG
-
BIIX 1 XX inhalation solution
single doses of 800, 1000, 1200, 1400, 1600, 1800, or 2000 mcg
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1999-01-31
- Primary Completion
- 1999-04-30
More Related Trials
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers
NCT01348165 ·Status: TERMINATED ·Phase: PHASE1
-
Single Rising Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Spray Dried BIBN 4096 BS After Inhalation Administration in Healthy Male and Female Volunteers
NCT02199860 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Men Tolerate Different Doses of BI 3006337
NCT05076422 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080
NCT04666922 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics After Administration of Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers
NCT02194322 ·Status: COMPLETED ·Phase: PHASE1
-
This Study in Healthy Men Tests How Different Doses of BI 1323495 Are Taken up in the Body and How Well They Are Tolerated.
NCT03588390 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects
NCT03195088 ·Status: TERMINATED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated
NCT06081530 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Administered to Healthy Male Subjects
NCT02211924 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Learn How BAY1817080 Moves Into, Through and Out of the Body and How Safe it is in Healthy Chinese Men
NCT04802343 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers
NCT03175211 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of Single Doses of BIIB059 in Healthy Japanese Subjects.
NCT03224793 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine Tolerability of Single Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers
NCT02194348 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated
NCT06148948 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Doses of BIIB063 in Healthy Volunteers
NCT02555085 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men
NCT05658107 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043
NCT04789304 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men
NCT06006598 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Dose Tolerability Study of BIBN 4096 BS in Healthy Male and Female Volunteers
NCT02198326 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated
NCT03747926 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 113608 in Healthy Asian and Caucasian Male Volunteers
NCT01922349 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers
NCT02183545 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of INX-08189 in Healthy Subjects
NCT01159808 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.
NCT01650155 ·Status: COMPLETED ·Phase: PHASE1
-
Increasing Dose Tolerance Study in Healthy Male Volunteers After Administration of BIII 890 CL
NCT02268136 ·Status: TERMINATED ·Phase: PHASE1